Monarch Capital Management Inc Viatris Inc Transaction History

Monarch Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$9.2 - $12.26 $24,324 - $32,415	-2,644 Reduced 14.01%	16,229 $156,000
Q4 2022 Jan 26, 2023	SELL	$8.72 - $11.56 $147,664 - $195,757	-16,934 Reduced 47.29%	18,873 $0
Q3 2022 Oct 20, 2022	SELL	$8.48 - $11.13 $80,772 - $106,013	-9,525 Reduced 21.01%	35,807 $305,000
Q2 2022 Jul 20, 2022	SELL	$9.95 - $12.27 $5,144 - $6,343	-517 Reduced 1.13%	45,332 $475,000
Q1 2022 Apr 20, 2022	SELL	$9.81 - $15.4 $4,434 - $6,960	-452 Reduced 0.98%	45,849 $499,000
Q4 2021 Jan 19, 2022	SELL	$12.09 - $14.68 $63,230 - $76,776	-5,230 Reduced 10.15%	46,301 $626,000
Q3 2021 Nov 04, 2021	SELL	$13.25 - $15.13 $2,477 - $2,829	-187 Reduced 0.36%	51,531 $698,000
Q2 2021 Jul 22, 2021	BUY	$12.97 - $16.15 $57,496 - $71,592	4,433 Added 9.38%	51,718 $739,000
Q1 2021 Apr 27, 2021	BUY	$13.59 - $18.54 $367,867 - $501,859	27,069 Added 133.9%	47,285 $661,000
Q4 2020 Jan 26, 2021	BUY	$14.3 - $18.74 $289,088 - $378,847	20,216 New	20,216 $379,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Monarch Capital Management Inc with notifications on news.